The record-breaking single-asset continuation fund was raised for health innovation platform Real Chemistry.
We dive into FLEX, outlining the performance, portfolio composition, and other details of the secondaries-focused tender offer fund, leveraging EvergreenLink Data.
We map the fair value, cost, and acquisition timeline for one of evergreen capital's most invested-in Q1 continuation funds.
We examine the Q4 capital flows, deployment activity, and performance of the secondaries-focused tender offer fund, leveraging EvergreenLink Data.
We examine the Q4 capital flows, investment activity, and returns of the secondaries-focused tender offer fund, leveraging EvergreenLink Data.
Institutional Link maps the fair value, cost, acquisition timeline, and more details for one of evergreen capital's most invested-in Q4 continuation funds.
Institutional Link maps the fair value, cost, acquisition timeline, and more details for perpetual capital's most invested-in Q4 continuation fund.
We examine the Q4 capital flows, investment activity, and performance of the tender offer fund, leveraging EvergreenLink Data.
Institutional Link analyzes the top performing '40 act secondary funds as of Q3 across one-, three-, and five-year periods, as the strategy continues to outperform peer groups.
The $1 billion combination of a solid waste management asset secured over $400 million in new equity capital, along with debt financing from a syndicate led by Ares Capital.
